Alpha 2.0
Login Register
» Articles » PMID: 11377136

Fenofibrate in Hyperlipidaemia Secondary to HIV Protease Inhibitors. Fenofibrate and HIV Protease Inhibitor

Overview
Journal Nutrition
Specialty Nutritional Sciences
Date 2001 May 30
PMID 11377136
Citations 5
Authors
D A de Luis
P Bachiller
R Aller
Affiliations
Soon will be listed here.
Citing Articles

Management of dyslipidemia in HIV-infected patients.

Malvestutto C, Aberg J Clin Lipidol. 2012; 6(4):447-462.

PMID: 22216062 PMC: 3249059. DOI: 10.2217/clp.11.25.

An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature.

Bruno C, Schapiro J, Saberi P J Int Assoc Physicians AIDS Care (Chic). 2011; 10(4):219-22.

PMID: 21518854 PMC: 3222949. DOI: 10.1177/1545109711404945.

Lipid management in patients who have HIV and are receiving HIV therapy.

Aberg J Endocrinol Metab Clin North Am. 2009; 38(1):207-22.

PMID: 19217520 PMC: 2753589. DOI: 10.1016/j.ecl.2008.11.009.

Evaluation and management of dyslipidemia in patients with HIV infection.

Green M J Gen Intern Med. 2002; 17(10):797-810.

PMID: 12390557 PMC: 1495116. DOI: 10.1046/j.1525-1497.2002.20201.x.

Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.

Keating G, Ormrod D Drugs. 2002; 62(13):1909-44.

PMID: 12215067 DOI: 10.2165/00003495-200262130-00013.